{"id":41027,"date":"2022-03-28T07:13:32","date_gmt":"2022-03-28T07:13:32","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=88962"},"modified":"2022-03-28T07:13:32","modified_gmt":"2022-03-28T07:13:32","slug":"vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs","status":"publish","type":"post","link":"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/","title":{"rendered":"Vela Diagnostics pr\u00e9sente ses panels de s\u00e9quen\u00e7age des g\u00e8nes du cancer cibl\u00e9s (60 g\u00e8nes) et complets (525 g\u00e8nes) bas\u00e9s sur les NGS"},"content":{"rendered":"
\n
\n
\n

HAMBOURG, Allemagne<\/span>, 28 mars\u00a02022\u00a0<\/span> \/PRNewswire\/\u00a0—\u00a0Vela Diagnostics a annonc\u00e9 aujourd’hui le lancement de ses nouveaux panels de s\u00e9quen\u00e7age OncoKey\u00ae<\/sup>\u00a0SL 60 et 525 Plus. Ces panels bas\u00e9s sur les syst\u00e8mes de s\u00e9quen\u00e7age de nouvelle g\u00e9n\u00e9ration\u00a0(NGS) sont con\u00e7us pour d\u00e9tecter les biomarqueurs d’ADN et d’ARN du cancer \u00e0 partir d’\u00e9chantillons de tissus fix\u00e9s au formol et inclus en paraffine\u00a0(FFPE), pour un maximum de 64\u00a0\u00e9chantillons par cycle de s\u00e9quen\u00e7age.<\/p>\n

Vela Diagnostics propose deux\u00a0panels de s\u00e9quen\u00e7age des g\u00e8nes du cancer\u00a0: le syst\u00e8me OncoKey\u00ae<\/sup>\u00a0SL 60 Plus et le syst\u00e8me complet OncoKey\u00ae<\/sup>\u00a0SL 525 Plus. Avec seulement 40\u00a0ng d’acide nucl\u00e9ique, le panel de s\u00e9quen\u00e7age peut d\u00e9tecter les biomarqueurs suivants en un\u00a0seul test\u00a0: polymorphisme d’un seul nucl\u00e9otide\u00a0(PSN), insertions ou d\u00e9l\u00e9tions\u00a0(indel), variations du nombre de copies\u00a0(copy number variations, CNV), instabilit\u00e9 des microsatellites\u00a0(microsatellite instability, MSI), fusions, \u00e9pissage alternatif, virus et bact\u00e9ries oncog\u00e8nes, et peut mesurer la charge mutationnelle tumorale\u00a0(CMT).<\/p>\n

Ces panels bas\u00e9s sur les NGS pr\u00e9sentent un flux de travail hautement automatis\u00e9, de l’\u00e9chantillon au r\u00e9sultat. Ils peuvent produire des r\u00e9sultats en cinq\u00a0jours, ne n\u00e9cessitent que 2,5\u00a0heures de travail manuel et assurent une tra\u00e7abilit\u00e9 \u00e9lev\u00e9e des \u00e9chantillons, de l’extraction automatis\u00e9e des \u00e9chantillons au contr\u00f4le de la qualit\u00e9\u00a0(CQ) des donn\u00e9es. VELA\u00ae <\/sup>Analytics permet de cr\u00e9er des rapports internes concis, fond\u00e9s sur des donn\u00e9es probantes, qui fournissent aux clients les informations n\u00e9cessaires pour prendre des d\u00e9cisions \u00e9clair\u00e9es quant aux options de traitement possibles. Par ailleurs, les laboratoires disposant de peu d’\u00e9chantillons peuvent choisir d’effectuer les tests manuellement.<\/p>\n

Le flux de travail des panels OncoKey\u00ae<\/sup>\u00a0SL 60 et 525 Plus repose sur les plateformes de s\u00e9quen\u00e7age Illumina. Les panels peuvent donc s’adapter sans probl\u00e8me aux situations actuelles des laboratoires. Associ\u00e9s \u00e0 des adaptateurs UMI-UDI doubles, \u00e0 un syst\u00e8me de capture par hybridation, \u00e0 un s\u00e9quen\u00e7age par synth\u00e8se et \u00e0 un pipeline bio-informatique valid\u00e9 avec soin, les panels pr\u00e9sentent une sensibilit\u00e9 \u00e9lev\u00e9e et un profilage complet des variantes, ainsi qu’une couverture de s\u00e9quen\u00e7age uniforme.<\/p>\n

\u00ab\u00a0Les panels OncoKey\u00ae<\/sup>\u00a060 et 525 Plus de VELA sont un formidable progr\u00e8s dans la m\u00e9decine de pr\u00e9cision pour le cancer, a d\u00e9clar\u00e9 le Dr Andreas\u00a0Goertz, directeur g\u00e9n\u00e9ral de la division europ\u00e9enne de Vela Diagnostics. Ces panels sont compos\u00e9s de g\u00e8nes pertinents d’un point de vue clinique et ont \u00e9t\u00e9 con\u00e7us sur la base de contributions de personnalit\u00e9s influentes dans le domaine de l’oncologie, ainsi que de r\u00e9f\u00e9rences \u00e0 des directives professionnelles, \u00e0 des essais cliniques et \u00e0 des bases de donn\u00e9es sur le cancer.\u00a0\u00bb<\/p>\n

\u00ab\u00a0Vela Diagnostics pr\u00e9voit de rendre disponibles les panels OncoKey\u00ae<\/sup>\u00a060 et 525 Plus au quatri\u00e8me\u00a0trimestre\u00a02022 aux \u00c9tats-Unis et en Asie-Pacifique, a ajout\u00e9 Sam\u00a0Dajani, PDG et pr\u00e9sident ex\u00e9cutif de Vela Diagnostics. L’utilisation de ces panels sur le flux de travail automatis\u00e9 de Vela Diagnostics permettra de r\u00e9duire les erreurs humaines et de minimiser la contamination crois\u00e9e des \u00e9chantillons qui peut \u00eatre engendr\u00e9e par un flux de travail manuel. Par ailleurs, nos solutions et services VELA\u00ae<\/sup>\u00a0Analytics peuvent identifier et interpr\u00e9ter les variantes g\u00e9n\u00e9tiques dans les tumeurs, ce qui permet de fournir rapidement et avec pr\u00e9cision des options exploitables aux professionnels de la sant\u00e9 et de la recherche.\u00a0\u00bb<\/p>\n

\u00c0 propos de Vela Diagnostics<\/b><\/p>\n

Vela Diagnostics est un fournisseur de premier plan de solutions int\u00e9gr\u00e9es de diagnostic in vitro<\/i>, de l’\u00e9chantillon au r\u00e9sultat. Les solutions de test de VELA utilisent la plateforme automatis\u00e9e Sentosa<\/i>\u00ae<\/sup>, et offrent la possibilit\u00e9 unique d’utiliser un seul syst\u00e8me pour les tests NGS et PCR dans le domaine des maladies infectieuses et de l’oncologie.<\/p>\n

Tous les produits Sentosa<\/i>\u00ae<\/sup> \u00e9num\u00e9r\u00e9s ci-dessus sont de Vela Diagnostics. Pour plus d’informations, consultez le site\u00a0www.veladx.com<\/a>. Tous les autres noms de produits, marques d\u00e9pos\u00e9es et logos sont la propri\u00e9t\u00e9 de leurs d\u00e9tenteurs respectifs.<\/p>\n

Contact pour les m\u00e9dias\u00a0:<\/b><\/p>\n

vince.yip@veladx.com<\/a><\/p>\n

 <\/p>\n<\/div>\n

\n

 <\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

HAMBOURG, Allemagne, 28 mars\u00a02022\u00a0 \/PRNewswire\/\u00a0\u2014\u00a0Vela Diagnostics a annonc\u00e9 aujourd\u2019hui le lancement de ses nouveaux panels de s\u00e9quen\u00e7age OncoKey\u00ae\u00a0SL 60 et 525 Plus. Ces panels bas\u00e9s sur les syst\u00e8mes de s\u00e9quen\u00e7age de nouvelle g\u00e9n\u00e9ration\u00a0(NGS) sont con\u00e7us pour d\u00e9tecter les biomarqueurs d\u2019ADN et d\u2019ARN du cancer \u00e0 partir d\u2019\u00e9chantillons de tissus fix\u00e9s au formol et inclus en [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31],"tags":[],"yoast_head":"\nVela Diagnostics pr\u00e9sente ses panels de s\u00e9quen\u00e7age des g\u00e8nes du cancer cibl\u00e9s (60 g\u00e8nes) et complets (525 g\u00e8nes) bas\u00e9s sur les NGS - South Africa Journal<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vela Diagnostics pr\u00e9sente ses panels de s\u00e9quen\u00e7age des g\u00e8nes du cancer cibl\u00e9s (60 g\u00e8nes) et complets (525 g\u00e8nes) bas\u00e9s sur les NGS - South Africa Journal\" \/>\n<meta property=\"og:description\" content=\"HAMBOURG, Allemagne, 28 mars\u00a02022\u00a0 \/PRNewswire\/\u00a0\u2014\u00a0Vela Diagnostics a annonc\u00e9 aujourd\u2019hui le lancement de ses nouveaux panels de s\u00e9quen\u00e7age OncoKey\u00ae\u00a0SL 60 et 525 Plus. Ces panels bas\u00e9s sur les syst\u00e8mes de s\u00e9quen\u00e7age de nouvelle g\u00e9n\u00e9ration\u00a0(NGS) sont con\u00e7us pour d\u00e9tecter les biomarqueurs d\u2019ADN et d\u2019ARN du cancer \u00e0 partir d\u2019\u00e9chantillons de tissus fix\u00e9s au formol et inclus en [\u2026]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/\" \/>\n<meta property=\"og:site_name\" content=\"South Africa Journal\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-28T07:13:32+00:00\" \/>\n<meta name=\"author\" content=\"sjadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"sjadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/\"},\"author\":{\"name\":\"sjadmin\",\"@id\":\"https:\/\/southafricajournal.com\/#\/schema\/person\/b5258049232dc72b42ad1073df5c990f\"},\"headline\":\"Vela Diagnostics pr\u00e9sente ses panels de s\u00e9quen\u00e7age des g\u00e8nes du cancer cibl\u00e9s (60 g\u00e8nes) et complets (525 g\u00e8nes) bas\u00e9s sur les NGS\",\"datePublished\":\"2022-03-28T07:13:32+00:00\",\"dateModified\":\"2022-03-28T07:13:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/\"},\"wordCount\":742,\"publisher\":{\"@id\":\"https:\/\/southafricajournal.com\/#organization\"},\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/\",\"url\":\"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/\",\"name\":\"Vela Diagnostics pr\u00e9sente ses panels de s\u00e9quen\u00e7age des g\u00e8nes du cancer cibl\u00e9s (60 g\u00e8nes) et complets (525 g\u00e8nes) bas\u00e9s sur les NGS - South Africa Journal\",\"isPartOf\":{\"@id\":\"https:\/\/southafricajournal.com\/#website\"},\"datePublished\":\"2022-03-28T07:13:32+00:00\",\"dateModified\":\"2022-03-28T07:13:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/southafricajournal.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vela Diagnostics pr\u00e9sente ses panels de s\u00e9quen\u00e7age des g\u00e8nes du cancer cibl\u00e9s (60 g\u00e8nes) et complets (525 g\u00e8nes) bas\u00e9s sur les NGS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/southafricajournal.com\/#website\",\"url\":\"https:\/\/southafricajournal.com\/\",\"name\":\"South Africa Journal\",\"description\":\"Hub for all the Latest News & Updates\",\"publisher\":{\"@id\":\"https:\/\/southafricajournal.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/southafricajournal.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/southafricajournal.com\/#organization\",\"name\":\"South Africa Journal\",\"url\":\"https:\/\/southafricajournal.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/southafricajournal.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/southafricajournal.com\/wp-content\/uploads\/2017\/08\/south-africa-journal.png\",\"contentUrl\":\"https:\/\/southafricajournal.com\/wp-content\/uploads\/2017\/08\/south-africa-journal.png\",\"width\":220,\"height\":111,\"caption\":\"South Africa Journal\"},\"image\":{\"@id\":\"https:\/\/southafricajournal.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/southafricajournal.com\/#\/schema\/person\/b5258049232dc72b42ad1073df5c990f\",\"name\":\"sjadmin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/southafricajournal.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"caption\":\"sjadmin\"},\"url\":\"https:\/\/southafricajournal.com\/author\/sjadmin-s\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vela Diagnostics pr\u00e9sente ses panels de s\u00e9quen\u00e7age des g\u00e8nes du cancer cibl\u00e9s (60 g\u00e8nes) et complets (525 g\u00e8nes) bas\u00e9s sur les NGS - South Africa Journal","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/","og_locale":"en_US","og_type":"article","og_title":"Vela Diagnostics pr\u00e9sente ses panels de s\u00e9quen\u00e7age des g\u00e8nes du cancer cibl\u00e9s (60 g\u00e8nes) et complets (525 g\u00e8nes) bas\u00e9s sur les NGS - South Africa Journal","og_description":"HAMBOURG, Allemagne, 28 mars\u00a02022\u00a0 \/PRNewswire\/\u00a0\u2014\u00a0Vela Diagnostics a annonc\u00e9 aujourd\u2019hui le lancement de ses nouveaux panels de s\u00e9quen\u00e7age OncoKey\u00ae\u00a0SL 60 et 525 Plus. Ces panels bas\u00e9s sur les syst\u00e8mes de s\u00e9quen\u00e7age de nouvelle g\u00e9n\u00e9ration\u00a0(NGS) sont con\u00e7us pour d\u00e9tecter les biomarqueurs d\u2019ADN et d\u2019ARN du cancer \u00e0 partir d\u2019\u00e9chantillons de tissus fix\u00e9s au formol et inclus en [\u2026]","og_url":"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/","og_site_name":"South Africa Journal","article_published_time":"2022-03-28T07:13:32+00:00","author":"sjadmin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"sjadmin","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/#article","isPartOf":{"@id":"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/"},"author":{"name":"sjadmin","@id":"https:\/\/southafricajournal.com\/#\/schema\/person\/b5258049232dc72b42ad1073df5c990f"},"headline":"Vela Diagnostics pr\u00e9sente ses panels de s\u00e9quen\u00e7age des g\u00e8nes du cancer cibl\u00e9s (60 g\u00e8nes) et complets (525 g\u00e8nes) bas\u00e9s sur les NGS","datePublished":"2022-03-28T07:13:32+00:00","dateModified":"2022-03-28T07:13:32+00:00","mainEntityOfPage":{"@id":"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/"},"wordCount":742,"publisher":{"@id":"https:\/\/southafricajournal.com\/#organization"},"articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/","url":"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/","name":"Vela Diagnostics pr\u00e9sente ses panels de s\u00e9quen\u00e7age des g\u00e8nes du cancer cibl\u00e9s (60 g\u00e8nes) et complets (525 g\u00e8nes) bas\u00e9s sur les NGS - South Africa Journal","isPartOf":{"@id":"https:\/\/southafricajournal.com\/#website"},"datePublished":"2022-03-28T07:13:32+00:00","dateModified":"2022-03-28T07:13:32+00:00","breadcrumb":{"@id":"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/southafricajournal.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/southafricajournal.com\/"},{"@type":"ListItem","position":2,"name":"Vela Diagnostics pr\u00e9sente ses panels de s\u00e9quen\u00e7age des g\u00e8nes du cancer cibl\u00e9s (60 g\u00e8nes) et complets (525 g\u00e8nes) bas\u00e9s sur les NGS"}]},{"@type":"WebSite","@id":"https:\/\/southafricajournal.com\/#website","url":"https:\/\/southafricajournal.com\/","name":"South Africa Journal","description":"Hub for all the Latest News & Updates","publisher":{"@id":"https:\/\/southafricajournal.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/southafricajournal.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/southafricajournal.com\/#organization","name":"South Africa Journal","url":"https:\/\/southafricajournal.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/southafricajournal.com\/#\/schema\/logo\/image\/","url":"https:\/\/southafricajournal.com\/wp-content\/uploads\/2017\/08\/south-africa-journal.png","contentUrl":"https:\/\/southafricajournal.com\/wp-content\/uploads\/2017\/08\/south-africa-journal.png","width":220,"height":111,"caption":"South Africa Journal"},"image":{"@id":"https:\/\/southafricajournal.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/southafricajournal.com\/#\/schema\/person\/b5258049232dc72b42ad1073df5c990f","name":"sjadmin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/southafricajournal.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","caption":"sjadmin"},"url":"https:\/\/southafricajournal.com\/author\/sjadmin-s\/"}]}},"_links":{"self":[{"href":"https:\/\/southafricajournal.com\/wp-json\/wp\/v2\/posts\/41027"}],"collection":[{"href":"https:\/\/southafricajournal.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/southafricajournal.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/southafricajournal.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/southafricajournal.com\/wp-json\/wp\/v2\/comments?post=41027"}],"version-history":[{"count":0,"href":"https:\/\/southafricajournal.com\/wp-json\/wp\/v2\/posts\/41027\/revisions"}],"wp:attachment":[{"href":"https:\/\/southafricajournal.com\/wp-json\/wp\/v2\/media?parent=41027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/southafricajournal.com\/wp-json\/wp\/v2\/categories?post=41027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/southafricajournal.com\/wp-json\/wp\/v2\/tags?post=41027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}